US Physical Therapy/$USPH
1D1W1MYTD1Y5YMAX
Capital at risk
About US Physical Therapy
US Physical Therapy Inc through its subsidiaries operate outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
- Ticker
- $USPH
- Sector
- Health
- Primary listing
- NYSE
- Employees
- 6,374
- Headquarters
- Houston, United States
- Website
- www.usph.com
USPH Metrics
BasicAdvanced
$1.2B
470.78
$0.18
1.13
$1.83
2.23%
Price and volume
Market cap
$1.2B
Beta
1.13
52-week high
$93.50
52-week low
$58.19
Average daily volume
173K
Dividend rate
$1.83
Financial strength
Current ratio
1.271
Quick ratio
1.12
Long term debt to equity
0.441
Total debt to equity
0.503
Dividend payout ratio (TTM)
85.50%
Interest coverage (TTM)
7.40%
Profitability
EBITDA (TTM)
102.009
Gross margin (TTM)
21.47%
Net profit margin (TTM)
4.01%
Operating margin (TTM)
9.90%
Effective tax rate (TTM)
26.06%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
4.10%
Return on equity (TTM)
6.51%
Valuation
Price to earnings (TTM)
470.779
Price to revenue (TTM)
1.557
Price to book
2.75
Price to tangible book (TTM)
-2.78
Price to free cash flow (TTM)
19.545
Free cash flow yield (TTM)
5.12%
Free cash flow per share (TTM)
4.229
Dividend yield (TTM)
2.21%
Forward dividend yield
2.23%
Growth
Revenue change (TTM)
11.36%
Earnings per share change (TTM)
-92.32%
3-year revenue growth (CAGR)
11.83%
10-year revenue growth (CAGR)
8.87%
3-year earnings per share growth (CAGR)
-55.03%
10-year earnings per share growth (CAGR)
-20.22%
3-year dividend per share growth (CAGR)
2.70%
10-year dividend per share growth (CAGR)
11.02%
What the Analysts think about USPH
Analyst ratings (Buy, Hold, Sell) for US Physical Therapy stock.
Analyst projections of the future price of US Physical Therapy stock.
Bulls say / Bears say
USPH’s core activity is gaining momentum: Q2 physical therapy revenue rose 8.4%, visits increased 6.6%, mature revenue grew 3.5% and revenue per visit increased by $2.26 year-on-year. Management reaffirmed 2026 adjusted EBITDA guidance of $102 million to $106 million. (U.S. Physical Therapy)
The two hospital affiliations cover 70 clinics; 31 were integrated by Q2 and the remaining 39 are expected to follow in Q3. Management estimates full integration could add at least $7.3 million of annualised USPH EBITDA, creating a visible earnings catalyst. (U.S. Physical Therapy, Business Wire)
Expansion remains supported by acquisitions and a steady second segment: 2026 acquisitions represent about $37.6 million of purchase price and $27 million of annualised revenue, while industrial injury prevention revenue rose 9.1% with a 20.4% margin in Q2. (U.S. Physical Therapy)
Profit conversion is weak: Q2 net income attributable to shareholders fell to $9.9 million from $12.4 million, while physical therapy margin fell to 19.5% from 21.2%. Higher employee medical costs and front-loaded staffing for hospital roll-outs are offsetting revenue growth. (U.S. Physical Therapy, Last10K)
The growth plan is increasing balance-sheet risk: credit-facility borrowings rose to $221.0 million from $161.8 million at 2025 year-end, while cash fell to $24.9 million from $35.6 million. Q2 interest expense also rose to $3.2 million from $2.4 million, leaving less room if earnings disappoint. (Last10K, U.S. Physical Therapy)
Industrial injury prevention growth is less impressive organically: Q2 revenue rose 9.1%, but only 3.6% excluding the January acquisition. This suggests the diversification benefit still depends partly on buying growth rather than stronger like-for-like demand. (U.S. Physical Therapy)
Data summarised monthly by Lightyear AI. Last updated on 19 Sept 2026.
USPH Financial Performance
Revenues and expenses
USPH Earnings Performance
Company profitability
Upcoming events
No upcoming events
USPH News
AllArticlesVideos
U.S. Physical Therapy Announces the Appointment of New Board Member Myra Davis
Business Wire4 days ago
U.S. Physical Therapy Bets on Hospital Alliances to Drive Visits, Reimbursement
MarketBeat4 weeks ago
U.S. Physical Therapy Presented at the 17th Annual Midwest Ideas Conference
Business Wire4 weeks ago
Funds containing USPH
AllUSDGBPEUR
Fund name | Fund size | $USPH weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.07% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.07% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.04% |
iShares MSCI World Small Cap$WSML | $9B | 0.01% |
iShares MSCI World Small Cap€IUSN | €7.8B | 0.01% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.